// App-Quantinova.ai

3869 : Different Prognosis According to Subtype-Oriented Protocols in Elderly Patients with Acute Lymphoblastic Leukemia (ALL). Comparison of Three Prospective Parallel Trials from the Pethema Group

Researchers

Presenter

  • Josep-Maria Ribera

Principal Investigators

  • Pascual Fernandez

  • Carmen Monteserin

  • Josep Sarra

  • Marta Fernandez

  • Mercedes Colorado

  • Andres Novo

  • Antonio Garcia

  • Maria Calbacho

  • Eugenia Abella

  • Maria-Jose Moreno

  • Jesus-Maria Hernandez-Rivas

  • Pau Montesinos

  • Maria-Elsa Lopez

  • Natalia Alonso

  • Alfons Serrano

  • Evarist Feliu

  • Salut Brunet

  • Maria del Pilar Martinez

  • Esperanza Lavilla

  • Teresa Bernal

  • Jose Gonzalez

  • Mar Tormo

  • Pere Barba

Medical Centers

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

  • Clinical Hematology Department, Hospital Universitario Central de Asturias, Asturias, Spain

  • IJC-ICO Badalona, Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain

  • Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucemia Josep Carreras, Universitat Autnoma de Barcelona, Badalona, Spain

  • Department of Hematology, ICO-Germans Trias i Pujol Hospital. Josep Carreras Leukemia Research Institute. Universitat Autnoma de Barcelona, Badalona, Spain

  • Hospital Universitario Clinico de Santiago, Santiago de Compostela, Spain

  • Hematology, Parc de Salut Mar, Barcelona, Spain

  • Hematologia, Hospital Universitario Vall de Hebron, Barcelona, Spain

  • Hematology and Hemotherapy, Virgen del Rocio University Hospital, Sevilla, Spain

  • Servicio Hematologia y Hemoterapia, Hospital Universitario Ramon y Cajal, Madrid, Spain

  • PETHEMA Group, Spanish Society of Hematology, Sevilla, Spain

  • Research Unit, Hospital General Universitario Alicante, Alicante, Spain

  • Pediatric Oncology, Hospital Universitari i Politecnic La Fe, Valencia, Spain

  • PETHEMA Group, Spanish Society of Hematology, Sevilla, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Nephrotoxicity

  • Lymphomas

  • Solid malignancies

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Lactate dehydrogenase

  • Lymphocyte count

  • White Blood Cell

Drug/Treatment

  • Allmercap

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Methotrexate

  • Rituximab

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved